A patient with
Creutzfeldt-Jakob disease (CJD), is set to be given a pioneering treatment,
which has been developed by Professor John Collinge and his team at the Medical Research Council
(MRC) Prion Unit at UCL.
Read: BBC News,
More: Daily Mail,
UCL News
Close
